Check out the following presentations, as part of W11: How Can We Use Randomized Trial Data to Assess Heterogeneity of Treatment Effects? Let Me Count The Ways – a workshop for the recent ISPOR 19th Annual International Meeting in Montreal.
How Can We Use RCT DATA to Assess Heterogeneity of Treatment Effects? Let Me Count The Ways – Robert W. Dubois, MD, PhD, Chief Scientist, National Pharmaceutical Council
HTE: Biologic and Non-Biologic Factors – C Daniel Mullins, PhD, Professor, Department of Pharmaceutical Health Services Research
Individual Patient Data and Meta-Analytic Techniques: Some Alternative Methods – Richard Willke, PhD, Group Lead, Outcomes & Evidence, Pfizer Inc.
These and other recently released presentations can be found on the ISPOR website. (Source: ISPOR, 2014).